Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Short term Debt (2018 - 2025)

Dna X filings provide 7 years of Short term Debt readings, the most recent being $171000.0 for Q4 2025.

  • On a quarterly basis, Short term Debt changed N/A to $171000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $171000.0, a N/A change, with the full-year FY2025 number at $171000.0, changed N/A from a year prior.
  • Short term Debt hit $171000.0 in Q4 2025 for Dna X, up from $37000.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $177000.0 in Q1 2021 to a low of $37000.0 in Q3 2023.
  • Median Short term Debt over the past 4 years was $147500.0 (2021), compared with a mean of $137833.3.
  • The widest YoY moves for Short term Debt: up 20.41% in 2021, down 98.25% in 2021.
  • Dna X's Short term Debt stood at $148000.0 in 2021, then fell by 0.68% to $147000.0 in 2022, then plummeted by 74.83% to $37000.0 in 2023, then soared by 362.16% to $171000.0 in 2025.
  • The last three reported values for Short term Debt were $171000.0 (Q4 2025), $37000.0 (Q3 2023), and $74000.0 (Q2 2023) per Business Quant data.